- Home
- LNTH vs BL Comparison
LNTH vs BL Comparison
Compare LNTH & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BL
- Stock Information
- Founded
- LNTH 1956
- BL 2001
- Country
- LNTH United States
- BL United States
- Employees
- LNTH N/A
- BL N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BL Computer Software: Prepackaged Software
- Sector
- LNTH Health Care
- BL Technology
- Exchange
- LNTH Nasdaq
- BL Nasdaq
- Market Cap
- LNTH 3.6B
- BL 3.1B
- IPO Year
- LNTH 2015
- BL 2016
- Fundamental
- Price
- LNTH $58.21
- BL $53.98
- Analyst Decision
- LNTH Strong Buy
- BL Hold
- Analyst Count
- LNTH 6
- BL 12
- Target Price
- LNTH $105.50
- BL $59.00
- AVG Volume (30 Days)
- LNTH 2.5M
- BL 954.3K
- Earning Date
- LNTH 08-06-2025
- BL 08-05-2025
- Dividend Yield
- LNTH N/A
- BL N/A
- EPS Growth
- LNTH N/A
- BL 48.84
- EPS
- LNTH 3.77
- BL 1.34
- Revenue
- LNTH $1,520,653,000.00
- BL $674,325,000.00
- Revenue This Year
- LNTH $4.57
- BL $10.09
- Revenue Next Year
- LNTH $9.41
- BL $8.69
- P/E Ratio
- LNTH $15.42
- BL $39.75
- Revenue Growth
- LNTH 5.75
- BL 8.00
- 52 Week Low
- LNTH $47.25
- BL $40.82
- 52 Week High
- LNTH $118.21
- BL $66.25
- Technical
- Relative Strength Index (RSI)
- LNTH 40.12
- BL 55.03
- Support Level
- LNTH $55.00
- BL $47.94
- Resistance Level
- LNTH $56.16
- BL $54.60
- Average True Range (ATR)
- LNTH 2.52
- BL 1.61
- MACD
- LNTH 0.57
- BL 0.40
- Stochastic Oscillator
- LNTH 41.41
- BL 90.69
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.